Introduction Nonalcoholic fatty liver disease (NAFLD) has become a rising concern, often called a “sleeper epidemic.” Affecting roughly 1 in 4 pati…
As a cardiovascular pharmacist, you will often hear debates on the optimal duration of dual antiplatelet therapy (DAPT) after stent placement in acut…
Finerenone (Kerendia) Finerenone, marketed as Kerendia 💊 is the first nonsteroidal mineralocorticoid receptor antagonist. Approved to slow CKD pro…
Bariatric surgery has become increasingly common as an effective solution for weight loss, diabetes control, and cardiovascular risk reduction. Recog…